New research compared the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. Here's what the study ...

New animal research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), reveals distinct metabolic adjustments to tirzepatide and semaglutide treatment ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference.

A major 72-week trial shows tirzepatide leads to double-digit weight ... shared decision-making. Further research is needed to determine which therapy best supports long-term weight loss in ...

Compared with semaglutide and insulin, tirzepatide was associated with improved ... Disclosure: This research was supported by Eli Lilly and Company. Please see the original reference for a ...

Investigators sourced data for this study from the TriNetX Analytics Research Network database. Patients (N=1,999,881) diagnosed with AF between 2022 and 2024 and who used tirzepatide for diabetes ...

It’s important to research a pharmacy before purchasing any compounded drugs. You can also ask a healthcare professional for their recommendations. Compounded tirzepatide has not undergone the ...

Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the mechanisms of action of tirzepatide – a drug known as Zepbound™ – on weight ...

Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the mechanisms of action of tirzepatide—a drug known as Zepbound—on weight ...

Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the mechanisms of action of tirzepatide – a drug known as Zepbound™ – on ...

While this study offered encouraging news for adults without diabetes, ongoing research will determine if tirzepatide offers similar long-term benefits for other groups. Investigations continue ...